Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib-MenC-TT Non-inferiority Study
NCT00258700Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Primary completion
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of Hib-MenC-TT in Meningococcal disease serogroup C (MenC), Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Feb 2005; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Meningococcal disease serogroup C (MenC)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00258700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258700.